ATA530876A - Verfahren zur herstellung eines neuen lebenden rabiesvirusstammes - Google Patents

Verfahren zur herstellung eines neuen lebenden rabiesvirusstammes

Info

Publication number
ATA530876A
ATA530876A AT530876A AT530876A ATA530876A AT A530876 A ATA530876 A AT A530876A AT 530876 A AT530876 A AT 530876A AT 530876 A AT530876 A AT 530876A AT A530876 A ATA530876 A AT A530876A
Authority
AT
Austria
Prior art keywords
producing
rabies virus
new living
virus stem
stem
Prior art date
Application number
AT530876A
Other languages
English (en)
Other versions
AT345450B (de
Original Assignee
Philips Roxane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Roxane filed Critical Philips Roxane
Publication of ATA530876A publication Critical patent/ATA530876A/de
Application granted granted Critical
Publication of AT345450B publication Critical patent/AT345450B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT530876A 1975-07-21 1976-07-19 Verfahren zur herstellung eines neuen lebenden rabiesvirusstammes AT345450B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/597,654 US4040904A (en) 1975-07-21 1975-07-21 Novel rabies virus vaccine and processes

Publications (2)

Publication Number Publication Date
ATA530876A true ATA530876A (de) 1978-01-15
AT345450B AT345450B (de) 1978-09-11

Family

ID=24392406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT530876A AT345450B (de) 1975-07-21 1976-07-19 Verfahren zur herstellung eines neuen lebenden rabiesvirusstammes

Country Status (15)

Country Link
US (1) US4040904A (de)
JP (1) JPS5218814A (de)
AT (1) AT345450B (de)
AU (1) AU1606576A (de)
BE (1) BE844353A (de)
DE (1) DE2632255A1 (de)
DK (1) DK323276A (de)
ES (1) ES449941A1 (de)
FR (1) FR2318652A1 (de)
GB (1) GB1551437A (de)
IT (1) IT1062543B (de)
NL (1) NL7607958A (de)
NZ (1) NZ181498A (de)
SE (1) SE7608206L (de)
ZA (1) ZA764124B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638985A5 (de) * 1979-04-10 1983-10-31 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff.
US4584194A (en) * 1980-07-30 1986-04-22 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4347239A (en) * 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4726946A (en) * 1980-07-30 1988-02-23 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
CA1249518A (en) * 1985-09-06 1989-01-31 Connaught Laboratories Limited Oral immunization of mammals
JP2667745B2 (ja) * 1991-03-11 1997-10-27 シャープ株式会社 電気音響変換器
CN101287838B (zh) 2005-10-14 2016-03-30 美国政府健康及人类服务部，疾病控制和预防中心 狂犬病病毒组合物和方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof

Also Published As

Publication number Publication date
AU1606576A (en) 1978-01-26
DE2632255A1 (de) 1977-02-17
IT1062543B (it) 1984-10-20
AT345450B (de) 1978-09-11
FR2318652A1 (fr) 1977-02-18
DK323276A (da) 1977-01-22
NZ181498A (en) 1978-06-02
SE7608206L (sv) 1977-01-22
GB1551437A (en) 1979-08-30
JPS5218814A (en) 1977-02-12
US4040904A (en) 1977-08-09
BE844353A (fr) 1977-01-20
ES449941A1 (es) 1977-07-01
NL7607958A (nl) 1977-01-25
ZA764124B (en) 1978-02-22

Similar Documents

Publication Publication Date Title
DD132786A5 (de) Verfahren zur herstellung eines neuen oximaethers
AT359642B (de) Verfahren zur herstellung eines neuen ring- peptids
AT355238B (de) Verfahren zur herstellung eines neuen hentriakontapeptids
AT356569B (de) Verfahren zur herstellung eines frost- bestaendigen betons
AT360670B (de) Verfahren zur herstellung eines neuen poly- peptides
AT343797B (de) Verfahren zur herstellung eines praparates zur behandlung interferonsensibler infektionskrankheiten
AT369742B (de) Verfahren zur herstellung eines neuen spiro-polycycloimidazolidindion-derivats
ATA628877A (de) Verfahren zur herstellung eines neuen wasser- loeslichen polymerisats
DD131762A5 (de) Verfahren zur herstellung eines pferde-rhinopneumonievakzins
AT345450B (de) Verfahren zur herstellung eines neuen lebenden rabiesvirusstammes
AT342768B (de) Verfahren zur herstellung eines neuen antibiotikums
AT347050B (de) Verfahren zur herstellung eines neuen 6-mehtyl- 8beta- (substituierten)-methylergolins
AT363593B (de) Verfahren zur herstellung eines neuen peptolidgemisches
AT370405B (de) Verfahren zur herstellung eines neuen ungesaettigten aldehyds
AT366056B (de) Verfahren zur herstellung eines phosphordichloridothiolats
AT348520B (de) Verfahren zur herstellung eines neuen tetrazolderivats
AT351185B (de) Verfahren zur herstellung eines neuen 11- desoxy-omega-pentanorprostaglandins
AT356295B (de) Verfahren zur herstellung eines neuen morphanderivates
AT338515B (de) Verfahren zur herstellung eines katalysators
AT348163B (de) Verfahren zur herstellung eines neuen prostaglandinderivates
AT352103B (de) Verfahren zur herstellung eines neuen dicyanovinylhydrazonomalonitrils
AT370061B (de) Verfahren zur herstellung eines zementes
ATA768178A (de) Verfahren zur herstellung eines neuen ring- peptids
ATA472979A (de) Verfahren zur herstellung eines neuen praevitamins
AT342767B (de) Verfahren zur herstellung eines neuen antibiotikums

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee